Home > Home Page Articles >
Stopping Ebola and Other Epidemics - Proudly Supporting Our Customers
Stopping Ebola and Other Epidemics
Proudly supporting our customers
Ebola is no longer front-page news, thanks to extraordinary international efforts to contain the virus. But it remains a threat to several West African countries, and without sustained commitment may once again wreak havoc in the region – and beyond.
Training on a Merck lab water system donated to a clinic in Lagos State, Nigeria
A Merck lab water installation at a clinic in Lagos State, Nigeria
We’re proud to count among our customers a number of leading biotech and pharmaceutical firms that are working around the clock to develop treatments and vaccines for Ebola other infectious diseases – to stop them in their tracks before they reach epidemic or pandemic proportions. We’re excited about the innovative work they’re doing and the opportunity to support their efforts through products and services that enable all stages of their research and production. Examples of our support include:
- Collaborating with Novavax, which is using our Pod filters in the rapid manufacturing process for its Zaire (Makona) Ebolavirus Glycoprotein Vaccine.
- Working to fast-track orders for critical single-use products to support treatments for Ebola and other infectious diseases in development by several key customers, including Crucell, GSK and Emergent BioSolutions.
We’re also supporting the fight against Ebola and other deadly epidemics through grants and direct donations:
To learn more, read about Merck's commitment to global health challenges: